Mind Medicine (MindMed) Inc. (MNMD)
MNMD Stock Price Chart
Explore Mind Medicine (MindMed) Inc. interactive price chart. Choose custom timeframes to analyze MNMD price movements and trends.
MNMD Company Profile
Discover essential business fundamentals and corporate details for Mind Medicine (MindMed) Inc. (MNMD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
15 Nov 2016
Employees
74.00
Website
https://www.mindmed.coCEO
Robert Barrow
Description
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.
MNMD Financial Timeline
Browse a chronological timeline of Mind Medicine (MindMed) Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 May 2026
Upcoming earnings on 6 Nov 2025
EPS estimate is -$0.50.
Earnings released on 31 Jul 2025
EPS came in at -$0.50 falling short of the estimated -$0.38 by -31.58%.
Earnings released on 8 May 2025
EPS came in at -$0.35 surpassing the estimated -$0.36 by +2.78%.
Earnings released on 6 Mar 2025
EPS came in at -$0.41 falling short of the estimated -$0.33 by -24.24%.
Earnings released on 7 Nov 2024
EPS came in at -$0.27 surpassing the estimated -$0.29 by +6.90%.
Earnings released on 13 Aug 2024
EPS came in at -$0.48 falling short of the estimated -$0.30 by -60.00%.
Earnings released on 8 May 2024
EPS came in at -$0.60 surpassing the estimated -$0.66 by +9.09%.
Earnings released on 28 Feb 2024
EPS came in at -$0.59 falling short of the estimated -$0.48 by -22.92%, while revenue for the quarter reached $4.84M .
Earnings released on 2 Nov 2023
EPS came in at -$0.53 surpassing the estimated -$0.65 by +18.46%.
Earnings released on 3 Aug 2023
EPS came in at -$0.72 falling short of the estimated -$0.54 by -33.33%.
Earnings released on 4 May 2023
EPS came in at -$0.51 falling short of the estimated -$0.41 by -24.39%.
Earnings released on 9 Mar 2023
EPS came in at -$0.27 surpassing the estimated -$0.49 by +44.90%.
Earnings released on 10 Nov 2022
EPS came in at -$0.56 surpassing the estimated -$0.58 by +3.45%.
Stock split effective on 29 Aug 2022
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 11 Aug 2022
EPS came in at -$0.60 surpassing the estimated -$0.75 by +20.00%.
Earnings released on 16 May 2022
EPS came in at -$0.60 surpassing the estimated -$0.75 by +20.00%.
Earnings released on 28 Mar 2022
EPS came in at -$0.75 falling short of the estimated -$0.70 by -7.14%.
Earnings released on 12 Nov 2021
EPS came in at -$0.90 falling short of the estimated -$0.52 by -73.08%.
Earnings released on 12 Aug 2021
EPS came in at -$1.35 falling short of the estimated -$0.60 by -125.00%.
Earnings released on 14 May 2021
EPS came in at -$0.57 .
Earnings released on 31 Dec 2020
EPS came in at -$0.48 .
Earnings released on 14 Nov 2020
EPS came in at -$0.45 matching the estimated -$0.45.
MNMD Stock Performance
Access detailed MNMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.